CLINICAL AND HISTOPATHOLOGICAL CORRELATIONS IN BOWEN'S DISEASE
Corresponding author:
[email protected]
Received
22 October 2021
Revised
3 November 2021
Accepted
12 November 2021
Available Online
15 November 2021
Abstract
BOWEN'S DISEASE (BD) IS AN IN SITU, PREINVASIVE CANCER WITH POTENTIAL FOR PROGRESSION IN SQUAMOUS CELL CARCINOMA (SCC), BEING CLINICALLY CONSIDERED A PRECANCER WITH A HIGH POTENTIAL FOR MALIGNANCY. THE AIMS OF THE STUDY WERE TO ASSES S THE CLINICAL, HISTOLOGICAL, AND EVOLUTIONARY ASPECTS OF THE BOWEN'S DISEASE AND INVASIVE BOWEN DISEASE. THE STUDIED GROUP COMPRISES 50 PATIENTS DIAGNOSED WITH BOWEN DISEASE OR INVASIVE BD, HOSPITALIZED IN THE DERMATOLOGY CLINIC OF EMERGENCY COUNTY HOSPIT AL OF CRAIOVA, BETWEEN 2010 AND MARCH 2021. THERE WERE 18 MALES AND 32 FEMALES, AGED 30 TO 85 YEARS, 66% OF THE PATIENTS BEING FROM THE URBAN ENVIRONMENT. THE MOST FREQUENT LOCALIZATION OF BD WAS AT THE LEVEL OF THE LIMBS (52%), ON PHOTOEXPOSED AREAS. IN 92% OF CASES, WE NOTICED CLINICAL ASPECT OF BD WITH SINGLE LESIONS AND THE TYPICAL FORM WAS PREDOMINANCE (80%). THE PATHOLOGY DIAGNOSED 41 BD AND 9 INVASIVE BD (SQUAMOUS CELL CARCINOMA). PRESUMPTIVE CLINICAL DIAGNOSIS IN 31 CASES (57.40%), WAS CONFIRMED BY HISTOPATHOLOGICAL EXAMINATION. THE CORRELATION OF CLINICAL, HISTOPATHOLOGICAL DATA LEAD TO AN ACCURATE DIAGNOSIS OF BD. BOWEN'S DISEASE, ALONG WITH OTHER KERATINOCYTIC PRECANCERS, BEING A STRONG PREDICTOR OF THE RISK OF DEVELOPING SKIN CARCINOMAS AND MELA NOMA, REQUIRING A PROMPT THERAPEUTIC ATTITUDE AND CAREFUL MONITORING.
Keywords
BOWEN DISEASE
SQUAMOUS CELL CARCINOMA
EPIDEMIOLOGY
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Dimitrescu A., Trifu P., Precancerele şi cancerele cutanate, Ed. Medicală, Bucureşti, 1992, 10- 74.
[2]
Markus V. Heppt, Gabriel Schlager, Carola Berking . Epithelial Precancerous Lesions In: Kang S., Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, Orringer J (eds), Fitzpatrik’s Dermatology in General Medicine, Nineth Edition, Mc Graw Hill Medical Companies, Inc., 2019, 1867-1871.
[3]
Boyd A. Tumors of the epidermis,In: Barnhill R.(Ed),Dermatopatology, th ird edition, Mc. Graw Hill Medical, Inc. 2010; 556-614.
[4]
Mun J. -H., Kim S. -H., J ung D. -S., Ko H. -C., Kwon K. -S., Kim M. -B.. Dermoscopic features of Bowen's disease in Asians. JEADV 2010; 24(7): 805-810.
[5]
Zalaudek I., Di Stefani A., Argenziano G. The specific dermatoscopic criteria of Bowen's disease. J Eur Acad Dermatol Venereol 2006; 20(3): 361-362.
[6]
Pătraşcu V., Tănase L.E. Aspecte epidemiologice, histopatologice şi clinic -evolutive ale carcinoamelor cutanate în judeţul Dolj-studiu pe 356 de cazuri. DermatoVenerol. (Buc), 2009; 54:13-20.
[7]
Hara H., Honda A., Suzuki H., Matsukura T . Detec tion of human papillomaviru s type 34 in Bowen's disease on the pubic area. JEADV, 2006; 20: 206-208.
[8]
Moldoveanu E., Popescu L.M ., Apoptoza – mecanisme moleculare, Ediţia a II -a, Ed. Universitară “Carol Davila”, Bucureşti, 1999, 21 -60.
[9]
Pulitzer MP, Beer TW, Cerio R, Kao GF, Murphy GF, Nagore E, Scolyer RA . Squamous cell carcinoma in situ (Bowen disease). In : Elder D., Massi D, Scolyer R, Willemze R (IARC Group). WHO Classification of skin tumours, 4th Edition. Lyon, 2018, 46-47. ISBN-13: 978-9283224402.
[10]
Quinn A.G., Perkins W. Non Melanoma skin cancer and other epidermal skin tumors In: Burns T, Breathnach S, Cox N, Griffiths C, Rook’s Textbook of Dermatology, Eighth edition, Wiley Blackwell Publising, Oxford, 2010, 2654 -2656.
[11]
Pătraşcu V., Boli dermatologice şi infecţii sexual -transmisibile. Ediţia a III -a, Ed. Sitech Craiova, 2014, 430-435, 449-464.
[12]
Dlugosz A., Yuspa S., Carcinogenesis Chemical. In: Wolff K, Goldsmith L., Katz S, Gilchrest B, Paller A, Leffell D (ed), Fitzpatri k’s Dermatology in General Medicine, Seventh Edition, Mc Graw Hill Medical Companies, Inc., 2008, 986 -994.
[13]
Zavos G., Karidis N.,Tsourouflis G., Bokos J., Diles K., Sotirchos G., Theodoropoulou E., Kostakis A . Nonmelanoma skin cancer after renal transplantation: a single -center experience in 1736 transplantations. International Journal of DErmatology 2011; 50: 1496 -1500.
[14]
Basset-Seguir N., Lebbe C., Proby C., Storey A., Oncogenes, Tumor Supressor Genes and Viral Carcinogenesis, In: Wolff K, Gol dsmith L., Katz S, Gilchrest B, Paller A, Leffell D (ed), Fitzpatrik’s Dermatology in General Medicine, Seventh Edition, Mc Graw Hill Medical Companies, Inc., 2008, 995-998.
[15]
Mitsuishi T., Kawashima M., Matsukura T., Sata T. Human papillomavirus type 58 in Bowen’s disease of the elbow. Br J Dermatol. 2001; 144:384-386.
[16]
Zheng S., Adachi A., Shimizu M., Shibata S -I., Yasue S., Sakakibara A., Sugiura M., Nagasaka T., Tomita Y. Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen’s disease. Br J Dermatol. 2005; 152:1243-1247.
[17]
Ekeowa-Anderson A.L., Harwood C.A., Perrett C.M. Vulval intraepithelial neoplasia and periungual Bowen’s disease concordant for mucosal (HPV -34) and epidermodysplasia verruciformis (HPV -
[21]
human papillomavirus types. Clin Exp Dermatol. 2007; 32:304-307.
[18]
Avram M.E., Costache I., Georgescu S.R., Benea V., Rusu A. Boală Bowen cutanată cu leziuni multiple. DermatoVenerol. 2007; 52: 157-159
[19]
Nishimura Y., Kishigawa T., Tanaka T. Bilateral Bowen's disease. British Journal of Dermatology 2004; 151: 227-228.
[20]
Duţu R., Diagnosticul morfologic al Carcinoamelor, Ed. Medical ă, Bucureşti, 1985, 37 - 88.
[21]
Iosif S ., Tatu A., Costache M. Boala Bowen cutanată şi pigmentară pe abdomenul inferior. Dermatovenerologie. 1998; 43: 119-121.
[22]
Reymann F., Ravnborg L., Schou G. Bowen’s disease and internal malignant diseases. A study of 581 patients. Arch Dermatol. 1988; 124:677-679.
[23]
Arbesman H. Ransohoff D.F. Is Bowen’s disease a predictor for the development of internal malignancy?A methodological critique of the literature. JAMA.1987; 257:516-518.
[24]
Jaeger A.B., Gramkow A., Hjalgrim H. Bowen disease and risk o f subsequent malignant neoplasms. Arch Dermatol. 1999; 135:790-793.
[25]
Schwartz RA. Premalignant keratinocytic neoplasms. J Am Acad Dermatol, 1996; 35: 223 -242.
[26]
Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (suppl.61): 1–6.
[27]
Murata Y., Kumano K., Sashikata T. Partial spontaneous regression of Bowen’s disease. Arch Dermatol. 1996; 132:429-432.